Dana Farber Cancer Institute SC-6

Boston, Massachusetts 02215

0 studies enrolling now · 2 studies all time

What they study most

Advanced Solid and Hematological TP53wt Tumors, Neuroendocrine Tumors

Studies at this site

• Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt — Completed
• Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs) — Completed